42 CFR Part 2 vs. HIPAA: What Treatment Centers Need to Know

Addiction treatment centers deal with two overlapping privacy frameworks, HIPAA and 42 CFR Part 2, and the marketing side often treats them as the same thing. They aren't. Part 2 is stricter in specific, practical ways that change how intake forms, CRMs, and tracking should be built.

What HIPAA covers, in short

HIPAA sets baseline privacy and security standards for protected health information across healthcare generally. It restricts who can access patient data, requires safeguards, and requires business associate agreements with vendors who touch that data. Most healthcare marketing compliance conversations start here.

What 42 CFR Part 2 adds on top

42 CFR Part 2 specifically protects records related to substance use disorder treatment at federally assisted programs. It's stricter than HIPAA in a few concrete ways that matter for marketing:

• Consent has to be specific to the disclosure. A general HIPAA-style authorization often isn't sufficient under Part 2, which typically requires consent naming who is disclosing, to whom, and for what purpose.
• Re-disclosure is restricted. Under Part 2, even a party who lawfully receives the information generally cannot pass it along further without additional consent, which affects how tracking and ad platform data-sharing should be evaluated.
• The mere fact that someone is a patient at a Part 2 program is itself protected information, not just their diagnosis or treatment details. That has direct implications for testimonials, reviews, and even something as simple as an admissions-form thank-you email that could confirm someone contacted a specific facility.

Where this shows up in a marketing stack

The practical difference between the two frameworks tends to show up in three places for a treatment center's marketing:

1. Intake and contact forms. A HIPAA-only mindset might treat a general privacy consent checkbox as sufficient. Part 2 generally calls for language specific to substance use treatment disclosures.
2. Analytics and ad platform tracking. Sending a conversion event that ties an identifiable visitor to a specific admissions inquiry can create Part 2 exposure even when the same setup would be a more manageable HIPAA question for a general medical practice.
3. Reviews and testimonials. Confirming someone is a patient at a Part 2 program, even indirectly through a review response, is a bigger exposure than the equivalent situation at a non-Part-2 medical practice.

What this means practically for a marketing program

It means the compliance review for a treatment center's marketing has to be built around Part 2's stricter consent and re-disclosure rules from the start, not adapted from a general HIPAA healthcare template after the fact. A tracking setup, form, or review-response process that would pass muster for a general medical practice may not be sufficient for a Part 2 program.

Tridigiam is a marketing agency, not a law firm. We build campaigns, forms, and tracking with Part 2's stricter standard in mind, and we flag anything that looks exposed, but the specific interpretation of Part 2 as it applies to your program should come from your own compliance counsel.

For the fuller picture of a compliant addiction treatment marketing program, see our Addiction Treatment Marketing: The Complete Guide.

Frequently asked questions

Does Part 2 apply to every addiction treatment provider?

Part 2 applies to programs that are federally assisted, which covers a large share of treatment providers but isn't automatically universal. Confirming your program's status with your compliance counsel is the right first step before assuming which framework governs a given piece of data.

Can we still use call tracking for a Part 2 program?

Call tracking itself isn't prohibited, but the consent and disclosure language around it needs to meet Part 2's stricter bar, and any vendor touching that data typically needs a qualified service organization agreement, which is Part 2's equivalent of a HIPAA BAA.

Is a HIPAA-compliant form automatically Part 2 compliant?

Not automatically. A form built to a general HIPAA standard may be missing the specific consent language Part 2 requires for substance use disclosures, so it's worth a dedicated review rather than assuming HIPAA compliance covers it.